Clinical trials involving over 1,900 obese adults who were unable to lose five percent of their body weight after a year of treatment with other medications demonstrated that semaglutide increased average weight loss from 2% to 20% over a treatment period of just over one year compared to a placebo
And thats exactly Usually, the, HIT, 80% are usually experienced by females, because of the estrogen connection
Int J Environ Res Public Health 2019;16:509.ArticlePubMedPMC 87
Our findings indicate that low-dose semaglutide did not reduce the weight of the TA, EDL, or soleus muscles
www.supergut.com Looking for a reprint of this article
It is worth noting that many clinical trials of GLP-1 agonists excluded people with significant psychiatric illness, which may limit our understanding of effects in these populations